Compare Mutual Funds

Pros
5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
2/11
10/11
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

14 Years

14 Years

Fund AUM

₹5870 Cr

₹9166 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1.01%

1%

Exit Load

0.5%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

38

40

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(11.14%)
  2. Divi's Laboratories Ltd(7.91%)
  3. Acutaas Chemicals Ltd(5.03%)
  4. Apollo Hospitals Enterprise Ltd(4.45%)
  5. Torrent Pharmaceuticals Ltd(4.42%)
  1. Sun Pharmaceuticals Industries Ltd(11.71%)
  2. Divi's Laboratories Ltd(7.1%)
  3. Lupin Ltd(6.17%)
  4. Cipla Ltd(6.01%)
  5. Dr Reddy's Laboratories Ltd(5.45%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(92.46%)
  2. Basic Materials(7.54%)

Health

(100%)

Equity %

95.53%

97.3%

Debt %

-

-

P/E

49.14

37.98

P/B

6.82

5.6

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

2.74%

1.64%

3-Month Return

0.54%

-0.65%

6-Month Return

16.43%

8.75%

1-Year Return

19.88%

10.54%

3-Year Return

25.15%

18.88%

5-Year Return

19.51%

14.54%

Sharpe

1.2

0.83

Alpha

3.24

-2.19

Beta

0.86

0.89

Standard Deviation

14.38

14.87

Information Ratio

0.41

-1.14

Description

SBI Healthcare Opportunities Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Tanmaya Desai

Sailesh Raj Bhan, Amber Singhania, Kinjal Desai

Most Popular Comparisons